Picture Kentro Design Corporate and Web Design for Start Ups 650x80px
Organisation › Details

Versameb AG

Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland managed by an experienced scientific and business pharmaceutical industry team. The company’s focus is the development of novel RNA-based therapeutics. Versameb’s proprietary VERSagile technology platform enables efficient development of functional mRNA molecules for customized protein expression and modification in multiple disease areas with high unmet medical need. *


Period Start 2018-01-30 existent
Products Industry VERSagile mRNA technology platform
  Industry 2 mRNA-based drug
Persons Person Metzger, Friedrich (Versameb 201910 CEO)
  Person 2 Ferreira, Isabel (Versameb 201910c– CBO before Roche Partnering + Prosensa)
Region Region Basel BS
  Country Switzerland
  Street 60C Hochbergerstr.
  City 4057 Basel BS
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: Versameb AG. (10/17/19). "Press Release: Versameb Raises CHF 6.4 Million in Seed C Round and Strengthens the Team". Basel.
Record changed: 2020-10-26


Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for Versameb AG

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [iito] Back into Ad 650x80px

» top